sur Ottobock SE & Co. KGaA
Ottobock Announces IPO Plans for 2025
Ottobock SE & Co. KGaA, a leader in the MedTech industry specializing in human bionics, has unveiled its intention to go public in 2025. The company aims to list on the Frankfurt Stock Exchange's Prime Standard, hoping to raise EUR 100 million through a mix of existing and new shares.
With a century-long history in innovation, Ottobock has pioneered advancements in prosthetics and neuro-orthotics. Its robust R&D infrastructure, featuring AI and digital manufacturing, supports its commitment to pushing technological boundaries.
The IPO aims to enhance financial flexibility, enabling Ottobock to continue investing in future tech. With strong revenue growth and a 22.4% EBITDA margin, the company is positioned for expansion in the growing global bionics market.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Ottobock SE & Co. KGaA